Myelopathy in systemic lupus erythematosus associated with antiphospholipid antibodies;Myelopathies lupiques et anticorps anti-phospholipides: 2 cas

Revue Neurologique

Volumn 153, Issue 2, 1997, Pages 138-140

  Feki, I ^a   Ben Hmida, M ^b   Masmoudi, H ^c   Triki, C ^d   Bahloul, Z ^e   Hachicha, J ^a   Jlidi, R ^b   Mhiri, C ^c  

^a HABIB BOURGUIBA HOSPITAL   (Tunisia)

^b Service de Néphrologie   (Tunisia)

^c Laboratoire de Microbiologie Immunologie   (Tunisia)

^d Service de Médecine Interne   (Tunisia)

^e HEDI CHAKER HOSPITAL   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; METHYLPREDNISOLONE; PHOSPHOLIPID ANTIBODY; PREDNISONE; GLUCOCORTICOID;

ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; PARAPLEGIA; PLEOCYTOSIS; SPINAL CORD DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; IMMUNOLOGY; PHYSIOLOGY; PROGNOSIS;

ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; FEMALE; GLUCOCORTICOIDS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; METHYLPREDNISOLONE; PREDNISONE; PROGNOSIS; SPINAL CORD DISEASES;

EID: 0031091097     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Alarcon-Segocia D., Deleze M., Oria C.V., Sanchez-Guerrero J., Gomez-Pacheco L, Cabiedes J., Fernandez L, Ponce de Leon S. (1989). Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus : a prospective analysis of 500 consecutive patients. Medicine, 68 :353-365.
2. Amor S., Asherson R.A., Webb H.E., Morris M.M., D'Cruz D., Khamashta M.A., Hughes G.R.V. (1992). Antibodies to Semliki Forest Virus (SFV) and galactocerebrosides (GACO) in SLE and primary antiphospholipid syndrome patients. Arthritis Rheum, 35 : S 362.
3. Bodiguel E. (1992). Anticorps antiphospholipides et système nerveux central. Rev Neural, 148 :655-662.
4. Chang R., Quismorio P.P. Jr. (1990). Transverse myelopathy in systemic lupus erythematosus (SLE). Arthritis Rheum, 33 : S 102.
5. Golstein M., Meyer O., Bourgeois P., Palazzo C., Nicaise P., Labarre C., Kahn M.F. (1993). Neurological manifestations of systemic lupus erythematosus : role of antiphospholipid antibodies. Clin Exp Rheum, 11 :373-379.
6. Hachulla E., Leys D., Deleume J.F., Pruvo J.P., Devulder B. (1995). Manifestations neurologiques associées aux anticorps antiphospholipides. Ou que reste-t-il du neurolupus ? Rev Med Interne, 16:121-130.
7. Khamashta M.A., Guadrado M.G., Mujic F., Taub N.A., Hunt B.J., Hugues G.R.V. (1995). The management of thrombosis in the antiphospholipid-antibody syndrome. N Engt J Med, 332 : 993997.
8. Laraki R., Blétry O., Piette J.C., Godeau P. (1991). Le syndrome des antiphospholipide. Sang Thrombose Vaisseaux, 3:363-369.
9. Levine S.R., Brey L.R., Sawaya K.L., Salowich-Palm L., Kokkinos J., Kostrzema B., Perry M., Havstad S., Carey J. (1995). Recurrent stroke and thrombo-oclusive events in the antiphospholipid syndrome. Ann Neurol, 38 :119-124.
10. Love P.E., Santoro S.A. (1990). Antiphospholipid antibodies : anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non SLE disorders : Prevalence and clinical significance. Ann Intern Med, 112 :682-698.